APP and Alzheimer disease: A study discovered an increased amyloid precursor protein (APP) load, in addition to a decreased insulin receptor activity in the brain of diabetes-induced (via intraperitoneal administration of streptozotocin) AD-transgenic hAPP (human-APP) mice [16].